Moderna’s COVID-19 vaccine for 6 to 17-year-olds faces CDC review

Advisors to the Centers for Disease Control and Prevention ready to decide whether to recommend modern Inc.’s COVID-19 vaccine for children ages 6 to 17.

aged children already have access for the Covid-19 vaccines made by pfizer Inc. and its partners BioNTech SE, Advisors are due on Thursday to discuss whether Moderna’s shot should also be made available for that age.